Edition:
United Kingdom

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

7.25USD
18 May 2018
Change (% chg)

$0.05 (+0.69%)
Prev Close
$7.20
Open
$7.15
Day's High
$7.32
Day's Low
$7.15
Volume
51,730
Avg. Vol
729,147
52-wk High
$10.65
52-wk Low
$1.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.20 December 23 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 2 2.83 3.15 2.50 --
Quarter Ending Sep-18 2 3.84 4.00 3.68 --
Year Ending Dec-18 2 17.41 17.75 17.08 13.32
Year Ending Dec-19 2 47.21 62.20 32.22 --
Earnings (per share)
Quarter Ending Jun-18 2 -0.20 -0.18 -0.22 --
Quarter Ending Sep-18 2 -0.19 -0.18 -0.20 --
Year Ending Dec-18 2 -0.93 -0.88 -0.97 -1.48
Year Ending Dec-19 2 -0.60 -0.52 -0.68 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 5.05 6.25 1.20 23.68
Quarter Ending Dec-17 12.73 20.41 7.67 60.28
Quarter Ending Sep-17 4.25 121.91 117.66 2,768.47
Quarter Ending Jun-17 4.34 4.66 0.33 7.51
Quarter Ending Mar-17 4.02 4.87 0.86 21.27

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 2.83 5.10 5.10 5.40 --
Quarter Ending Sep-18 3.84 5.90 5.90 6.00 --
Year Ending Dec-18 17.41 24.42 20.05 24.15 13.32
Year Ending Dec-19 47.21 50.21 50.21 57.80 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 1 0 1
Quarter Ending Sep-18 0 1 0 1
Year Ending Dec-18 0 1 1 1
Year Ending Dec-19 0 1 0 1
Earnings